Nutrition Research
Volume 28, Issue 5 , Pages 321-328 , May 2008

Butyrate and trichostatin A attenuate nuclear factor κB activation and tumor necrosis factor α secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells

  • Makoto Usami

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 78 796 4591; fax: +81 78 796 4509.
    • ,
  • Kazunori Kishimoto

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Atsushi Ohata

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Makoto Miyoshi

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • Department of Medical Technology, Faculty of Health Science, Kagawa Prefectural College of Health Sciences, Japan
    • ,
  • Michiko Aoyama

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Yuri Fueda

      Affiliations

    • Division of Surgical Metabolism, Faculty of Health Science, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Joji Kotani

      Affiliations

    • Department of Emergency and Critical Care Medicine, Hyogo College of Medicine, Nishinomiya, Japan

Received 21 September 2007 ,Revised 4 January 2008 ,Accepted 11 February 2008.

References 

  1. Buetler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious disease. Crit Care Med. 1992;21(Suppl):S423–S435
  2. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and the cell response in injury. Surgery. 2000;127:117–126
  3. Grimble RF. Interaction between nutrients, pro-inflammatory cytokines and inflammation. Clin Sci. 1996;91:121–130
  4. van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;14:413–426
  5. Quivy V, Lint CV. Regulation at multiple levels of NF-kB–mediated transcription by protein acetylation. Biochem Pharm. 2004;68:1221–1229
  6. Suuronen T, Huuskonen J, Pihlaja R, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem. 2003;87:407–416
  7. Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time?. Nutr Clin Prac. 2006;21:651–666
  8. Della Ragione F, Criniti V, Della Pietra V, Borriello A, Oliva A, Indaco S, et al. Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett. 2001;499:199–204
  9. Taniura S, Kamitani H, Watanabe T, Eling TE. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J Biol Chem. 2002;277:16823–16830
  10. Park GY, Joo M, Pedchenko T, Blackwell TS, Christman JW. Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. Am J Physiol Lung Cell Mol Physiol. 2004;286:L956–L962
  11. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut. 2000;47:397–403
  12. Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEBJ. 2000;14:2380–2382
  13. Nancey S, Bienvenu J, Coffin B, Andre F, Descos L, Flourié B. Butyrate strongly inhibits in vivo stimulated release of cytokines in blood. Dig Dis Sci. 2002;47:921–928
  14. Cavaglieeri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003;73:1683–1690
  15. Perez R, Stevenson F, Johnson J, Morgan M, Erickson K, Hubbard NE, et al. Sodium butyrate up-regulates Kupffer cell PGE2 production and modulates immune function. J Surg Res. 1998;78:1–6
  16. Takahashi HK, Iwahaki H, Yoshino T, Mori S, Morichika T, Itoh H, et al. Prostaglandin E2 inhibits IL-18–induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J Immmunol. 2002;168:4446–4454
  17. Drozdowski LA, Dixon WT, McBurney MI, Thomson AB. Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN. 2002;26:145–150
  18. Ohata A, Usami M, Miyoshi M. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition. 2005;21:838–847
  19. Egorin MJ, Yuan ZM, Sentz DL, Plaisance K, Eiseman JL. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol. 1999;43:445–453
  20. Lowry OH, Rosenbrough NJ, Farr Al, Randoall R. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275
  21. James MJ, Penglis PS, Caughey GE, Demasi M, Cleland LG. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm Res. 2001;50:249–253
  22. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:S2485–S2493
  23. Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release. Asaio J. 1992;38:52–54
  24. Poul EL, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481–25489
  25. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003;303:1047–1052
  26. Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, et al. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res. 1998;4:629–634
  27. Bengmark S. Probiotics, prebiotics, and synbiotics in the intensive care unit. In:  Shikora SA,  Martindale RG,  Schwaitzberg SD editor. Nutritional considerations in the intensive care unit. A.S.P.E.N. Dubuque: Kendall/Hunt; 2002;p. 383–399

PII: S0271-5317(08)00040-7

doi: 10.1016/j.nutres.2008.02.012

Nutrition Research
Volume 28, Issue 5 , Pages 321-328 , May 2008

Article Tools

* Image Usage & Resolution